4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Adaptive Biotechnologies Corporation (ADPT) operates in the Diagnostics & Research industry and is headquartered in Seattle, United States with about 624 employees. Its market capitalization is roughly $4 billion. In the fiscal year ended 2025-12-31, ADPT reported $277M in revenue and ($60M) in net income.
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.
Interactive charts & full statements → Open the ADPT valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $277M | $179M | $170M | $185M |
| Gross Profit | $206M | $107M | $95M | $127M |
| Operating Income (EBIT) | ($57M) | ($155M) | ($202M) | ($200M) |
| Net Income | ($60M) | ($160M) | ($225M) | ($200M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $71M | $72M | $94M | $59M | $52M | — |
| Gross Profit | $52M | $54M | $76M | $41M | $36M | — |
| Operating Income (EBIT) | ($19M) | ($13M) | $10M | ($25M) | ($30M) | — |
| Net Income | ($20M) | ($14M) | $10M | ($26M) | ($30M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $513M | $539M | $661M | $857M | — |
| Total Liabilities | $288M | $337M | $353M | $392M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ADPT viewer.
About TickerBase · Data methodology & sources